[Implementation and indications for quantitative sialoscintigraphy]

Standard

[Implementation and indications for quantitative sialoscintigraphy]. / Bohuslavizki, K H; Brenner, Winfried; Klutmann, S; Tinnemeyer, S; Werner, J A; Mester, J; Clausen, M; Henze, E.

in: LARYNGO RHINO OTOL, Jahrgang 76, Nr. 10, 10, 1997, S. 614-624.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Bohuslavizki, KH, Brenner, W, Klutmann, S, Tinnemeyer, S, Werner, JA, Mester, J, Clausen, M & Henze, E 1997, '[Implementation and indications for quantitative sialoscintigraphy]', LARYNGO RHINO OTOL, Jg. 76, Nr. 10, 10, S. 614-624. <http://www.ncbi.nlm.nih.gov/pubmed/9445528?dopt=Citation>

APA

Bohuslavizki, K. H., Brenner, W., Klutmann, S., Tinnemeyer, S., Werner, J. A., Mester, J., Clausen, M., & Henze, E. (1997). [Implementation and indications for quantitative sialoscintigraphy]. LARYNGO RHINO OTOL, 76(10), 614-624. [10]. http://www.ncbi.nlm.nih.gov/pubmed/9445528?dopt=Citation

Vancouver

Bohuslavizki KH, Brenner W, Klutmann S, Tinnemeyer S, Werner JA, Mester J et al. [Implementation and indications for quantitative sialoscintigraphy]. LARYNGO RHINO OTOL. 1997;76(10):614-624. 10.

Bibtex

@article{168e5062fe524ad0af53a68d6c495f96,
title = "[Implementation and indications for quantitative sialoscintigraphy]",
abstract = "BACKGROUND: Since its introduction in 1965 salivary gland scintigraphy has been an established method to simultaneously investigate excretion function in major salivary glands. In order to elucidate parenchymal function of salivary glands, several authors described various quantitative and semiquantitative methods. However, no standardized protocol for quantitative salivary gland scintigraphy has been established so far. METHODS: Therefore, in this paper we report on a standardized and validated acquisition protocol for salivary gland scintigraphy using 99mTc-pertechnetate. RESULTS: A normal data base for both parenchymal and excretion function is given in detail. In addition, the diagnostic value of salivary gland scintigraphy is reviewed in various clinical settings, such as mild parenchymal damage in beginning Sj{\"o}gren's syndrome, proof of functional obstruction in sialolithiasis with and without parenchymal damage, and parenchymal damage following radioiodine treatment. In a second part, applications of salivary gland scintigraphy in current clinical research are described, and radiation protection of salivary glands in rabbits and patients treated with high doses of I-131 are discussed. CONCLUSIONS: Salivary gland scintigraphy is a study that is easily performed and well tolerated by the patient. It yields quantitative parameters for parenchymal function and excretion fraction.",
author = "Bohuslavizki, {K H} and Winfried Brenner and S Klutmann and S Tinnemeyer and Werner, {J A} and J Mester and M Clausen and E Henze",
year = "1997",
language = "Deutsch",
volume = "76",
pages = "614--624",
journal = "LARYNGO RHINO OTOL",
issn = "0935-8943",
publisher = "Georg Thieme Verlag KG",
number = "10",

}

RIS

TY - JOUR

T1 - [Implementation and indications for quantitative sialoscintigraphy]

AU - Bohuslavizki, K H

AU - Brenner, Winfried

AU - Klutmann, S

AU - Tinnemeyer, S

AU - Werner, J A

AU - Mester, J

AU - Clausen, M

AU - Henze, E

PY - 1997

Y1 - 1997

N2 - BACKGROUND: Since its introduction in 1965 salivary gland scintigraphy has been an established method to simultaneously investigate excretion function in major salivary glands. In order to elucidate parenchymal function of salivary glands, several authors described various quantitative and semiquantitative methods. However, no standardized protocol for quantitative salivary gland scintigraphy has been established so far. METHODS: Therefore, in this paper we report on a standardized and validated acquisition protocol for salivary gland scintigraphy using 99mTc-pertechnetate. RESULTS: A normal data base for both parenchymal and excretion function is given in detail. In addition, the diagnostic value of salivary gland scintigraphy is reviewed in various clinical settings, such as mild parenchymal damage in beginning Sjögren's syndrome, proof of functional obstruction in sialolithiasis with and without parenchymal damage, and parenchymal damage following radioiodine treatment. In a second part, applications of salivary gland scintigraphy in current clinical research are described, and radiation protection of salivary glands in rabbits and patients treated with high doses of I-131 are discussed. CONCLUSIONS: Salivary gland scintigraphy is a study that is easily performed and well tolerated by the patient. It yields quantitative parameters for parenchymal function and excretion fraction.

AB - BACKGROUND: Since its introduction in 1965 salivary gland scintigraphy has been an established method to simultaneously investigate excretion function in major salivary glands. In order to elucidate parenchymal function of salivary glands, several authors described various quantitative and semiquantitative methods. However, no standardized protocol for quantitative salivary gland scintigraphy has been established so far. METHODS: Therefore, in this paper we report on a standardized and validated acquisition protocol for salivary gland scintigraphy using 99mTc-pertechnetate. RESULTS: A normal data base for both parenchymal and excretion function is given in detail. In addition, the diagnostic value of salivary gland scintigraphy is reviewed in various clinical settings, such as mild parenchymal damage in beginning Sjögren's syndrome, proof of functional obstruction in sialolithiasis with and without parenchymal damage, and parenchymal damage following radioiodine treatment. In a second part, applications of salivary gland scintigraphy in current clinical research are described, and radiation protection of salivary glands in rabbits and patients treated with high doses of I-131 are discussed. CONCLUSIONS: Salivary gland scintigraphy is a study that is easily performed and well tolerated by the patient. It yields quantitative parameters for parenchymal function and excretion fraction.

M3 - SCORING: Zeitschriftenaufsatz

VL - 76

SP - 614

EP - 624

JO - LARYNGO RHINO OTOL

JF - LARYNGO RHINO OTOL

SN - 0935-8943

IS - 10

M1 - 10

ER -